RVO Health’s Mukund Jain joins healthcare advertising leader John Mangano to unpack the “magic moment” when patients and providers meet — and why every dollar of healthcare marketing ultimately succeeds or fails right there. Mukund explains how emotion, evidence, and empathy collide in those eight-ish critical minutes that define patient outcomes and brand success.

Mukund shares his journey from biomedical engineer to healthcare marketing leader. He reveals how structural and cultural divides between HCP and DTC marketing can create friction, and how shared language, unified KPIs, and conversation-ready strategies can turn that friction into connection.

The conversation looks ahead to a more integrated, AI-enabled marketing future where personalization becomes the connective tissue between patients and providers. Mukund and John cover how ad tech can quietly enable that alignment, not by selling harder, but by helping both sides meet in the middle.

Connected TV (CTV) is rewriting the possibilities of pharma marketing. In this episode, John Mangano talks with Toby Katcher, SVP of Video Strategy and Investment at CMI Media Group, about how CTV is changing the way healthcare brands reach patients and HCPs. Toby explains how data, precision targeting, and interactivity are making TV measurable, accountable, and more personal than ever. From niche patient segments to clinician engagement, this conversation reveals how modern video strategies are redefining impact. Tune in to learn why the future of healthcare advertising starts on the biggest screen in the house.

Reaching patients with rare diseases takes more than broad reach; it takes precision, empathy, and smart data. In this episode, Kate Gattuso Duffy, Global Lead of Media Measurement, Optimization, and Web Analytics at Pfizer, joins healthcare marketing leader John Mangano to discuss how data-driven marketing can make a life-changing impact.

Kate shares how her team uses audience insights and analytics to connect with hard-to-reach populations, reduce waste, and design campaigns that truly serve patients. She and John dive into what it really means to “meet people where they are,” navigate bias in data, and balance rigor with curiosity in every campaign.

It’s a conversation about using data with purpose and how precision makes marketing more meaningful for patients.

Healthcare marketing is evolving, and policy is a big part of that story. From conversations about drug advertising to new ideas like tariffs on imported medicines, there’s a lot happening that could reshape how the industry communicates with patients and providers.

In this episode, Jim Potter, Executive Director of the Coalition for Healthcare Communication, joins health advertising expert John Mangano to break down the latest proposals and what they might mean in practice, from ad rules and tax policy to efforts to bring more drug manufacturing back to the U.S. You’ll hear why some ideas generate headlines but face big legal and practical hurdles, and how industry groups are preparing for what comes next.

Most importantly, we highlight how smart communication can support better health outcomes and why advertising plays a bigger role than many realize. It’s a thoughtful look at the balance between policy, industry, and patient needs, with abundant insights for anyone curious about where healthcare is headed.

In this episode, we bring you a powerhouse panel of industry leaders exploring how data and technology are transforming healthcare marketing. From the early days of marrying health data with media insights to today’s AI-fueled acceleration, our speakers dive into how speed, personalization, and smarter outcomes are redefining the playbook for pharma campaigns. You’ll hear how agencies, pharma brands, and analytics experts are approaching the next frontier of real-time optimization in healthcare.

Together, they tackle big questions: How can AI empower planners, buyers, and data scientists without losing the human touch? How do we break down the silos of fragmented dashboards and create unified, actionable insights? And what does it really mean to balance innovation with privacy guardrails, regulatory oversight, and patient-first thinking? The conversation is candid, practical, and packed with sharp perspectives on the opportunities and risks ahead.

Looking toward the future, the panelists share their vision of what’s next—whether it’s the rise of citizen data scientists, new streams of health data from wearables and telehealth, or the evolution of personalized patient journeys. Above all, they agree on one thing: the goal isn’t just efficiency or optimization. It’s using smarter data and technology to deliver better outcomes for patients. Tune in for a lively, thought-provoking discussion that will leave you rethinking how healthcare marketing works today—and where it’s headed tomorrow.

What happens when a marketer who’s led powerful campaigns in fast-moving industries like CPG, retail, and financial services brings that experience to pharma? Erin Nocito, Executive Director and Head of Global Media at Amgen, shares how she’s turned healthcare's famously complex rulebook into a platform for creativity, purpose, and impact.

In this episode, Erin reflects with healthcare marketing leader John Mangano on the steep learning curve of moving into healthcare, the unexpected freedom that comes with working in a highly regulated environment, and the lessons she’s carried over from brands like Walmart and Dawn. She dives into how pharma has quietly gotten ahead of other industries in areas like data responsibility, and why connecting doctors and patients through better communication is at the heart of meaningful marketing.

From navigating regulations to seizing opportunities for innovation, Erin shows that thriving in pharma isn’t about working around the rules but embracing them.

Bill Veltre, EVP and Head of Media at Deerfield, joins healthcare advertising leader John Mangano on Deep to share sharp insights from a career spanning agencies, brands, and the frontlines of healthcare marketing. From mastering the art of bite-sized content for distracted audiences to building authentic partnerships between clients, agencies, and partners, Bill unpacks what it really takes to connect in today’s crowded media landscape.

In this fast-moving conversation, he explores how data, technology, and curiosity fuel better storytelling, whether it’s tailoring messages for overburdened HCPs, making patient communications resonate, or leveraging next best action strategies that actually work. Along the way, he challenges the idea that pharma is “behind,” pointing to innovations in AI, personalization, and real-time measurement already transforming the industry.

Full of practical wisdom and candid perspective, this episode delves into how the most effective marketing starts with empathy, agility, and a deep understanding of your audience. It also highlights why the next 24 months will transform what's possible in healthcare communication.

Healthcare marketing leader John Mangano sits down with Jameson Fleming, Editor in Chief of MM+M, to explore how his journey from sports journalism to pharma media informs his perspective on health advertising. Drawing from his experience at CBS Sports, Adweek, and now MM+M, Jameson shares his audience-first approach and emphasizes the need for human-centered storytelling in pharma marketing.

The conversation covers the industry's creative constraints and why they're no reason for uninspired work. Jameson discusses the importance of integrating more outside thinking into the industry, the missed opportunity of patient-led narratives, and how pharma can better tap into trends like social listening and connected TV (CTV) to improve reach and resonance.

Jameson also offers candid views on drug pricing transparency, the future of direct-to-consumer advertising, and his vision for evolving MM+M into a daily go-to resource. His message to both pharma marketers and legislators is clear: innovation, education, and openness are the keys to building trust and delivering better outcomes.